Geode Capital Management, LLC Chroma Dex Corp. Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Geode Capital Management, LLC holds 561,059 shares of CDXC stock, worth $1.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

561,059

Previous 503,943 11.33%

Holding current value

$1.53 Million

Previous $720,000 171.11%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.36 - $3.84 $77,677 - $219,325	57,116 Added 11.33%	561,059 $1.95 Million
Q3 2023 Nov 13, 2023	SELL	$1.36 - $1.77 $27,820 - $36,207	-20,456 Reduced 3.9%	503,943 $735,000
Q2 2023 Aug 11, 2023	SELL	$1.31 - $1.79 $43,277 - $59,134	-33,036 Reduced 5.93%	524,399 $823,000
Q1 2023 May 15, 2023	SELL	$1.48 - $2.19 $2,092 - $3,096	-1,414 Reduced 0.25%	557,435 $852,000
Q4 2022 Feb 13, 2023	BUY	$1.46 - $1.94 $8,065 - $10,716	5,524 Added 1.0%	558,849 $938,000

Q3 2022 Nov 14, 2022	BUY	$1.21 - $2.06 $5,551 - $9,451	4,588 Added 0.84%	553,325 $680,000
Q2 2022 Aug 12, 2022	SELL	$1.59 - $2.7 $596,768 - $1.01 Million	-375,326 Reduced 40.62%	548,737 $916,000
Q1 2022 May 13, 2022	BUY	$2.02 - $3.92 $86,445 - $167,756	42,795 Added 4.86%	924,063 $2.27 Million
Q4 2021 Feb 11, 2022	BUY	$3.74 - $6.7 $63,781 - $114,261	17,054 Added 1.97%	881,268 $3.3 Million
Q3 2021 Nov 12, 2021	BUY	$6.05 - $10.41 $263,066 - $452,647	43,482 Added 5.3%	864,214 $5.42 Million
Q2 2021 Aug 13, 2021	BUY	$6.66 - $10.92 $566,066 - $928,145	84,995 Added 11.55%	820,732 $8.09 Million
Q1 2021 May 12, 2021	BUY	$4.59 - $18.74 $364,042 - $1.49 Million	79,312 Added 12.08%	735,737 $6.87 Million
Q4 2020 Feb 12, 2021	BUY	$3.93 - $5.5 $104,494 - $146,239	26,589 Added 4.22%	656,425 $3.15 Million
Q3 2020 Nov 13, 2020	BUY	$4.01 - $5.56 $67,584 - $93,708	16,854 Added 2.75%	629,836 $2.53 Million
Q2 2020 Aug 13, 2020	BUY	$3.0 - $5.52 $76,050 - $139,932	25,350 Added 4.31%	612,982 $2.81 Million
Q1 2020 May 14, 2020	BUY	$2.54 - $4.75 $225,295 - $421,320	88,699 Added 17.78%	587,632 $1.92 Million
Q4 2019 Feb 13, 2020	BUY	$2.83 - $4.61 $186,106 - $303,162	65,762 Added 15.18%	498,933 $2.15 Million
Q3 2019 Nov 12, 2019	BUY	$3.83 - $4.72 $58,277 - $71,819	15,216 Added 3.64%	433,171 $1.7 Million
Q2 2019 Aug 14, 2019	BUY	$3.71 - $4.83 $142,167 - $185,085	38,320 Added 10.09%	417,955 $1.94 Million
Q1 2019 May 14, 2019	BUY	$3.2 - $4.19 $105,318 - $137,901	32,912 Added 9.49%	379,635 $1.59 Million
Q4 2018 Feb 13, 2019	BUY	$2.8 - $4.22 $48,610 - $73,263	17,361 Added 5.27%	346,723 $1.19 Million
Q3 2018 Nov 13, 2018	BUY	$3.5 - $4.91 $119,430 - $167,543	34,123 Added 11.56%	329,362 $1.41 Million
Q2 2018 Aug 14, 2018	BUY	$3.22 - $4.43 $385,762 - $530,722	119,802 Added 68.29%	295,239 $1.1 Million
Q3 2017 Nov 14, 2017	BUY	$2.91 - $4.71 $25,427 - $41,155	8,738 Added 5.24%	175,437 $754,000
Q2 2017 Aug 14, 2017	BUY	N/A	166,699	166,699 $636,000

Others Institutions Holding CDXC

# of Institutions

Shares Held

13.1M

Call Options Held

97.1K

Put Options Held

17.6K

View Full List

About ChromaDex Corp.

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $187M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

More about CDXC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Chroma Dex Corp. Transaction History